Apr 16 2019 Cerebral Therapeutics Strengthens Clinical Development Leadership with Strategic Appointments
Apr 15 2019 W. Mark Watson Elected a s Chairman of the Board of HedgePath Pharmaceuticals
Apr 11 2019 KemPharm Completes KP415 Pre-NDA Meeting with FDA
Apr 28-May 2 2019 ARVO Annual Meeting
May 2-3 2019 ThinkEquity Conference
May 3-6 2019 American Academy of Neurology
May 7-9 2019 Deutche Bank Annual Healthcare Conference
Hospital antibiotic developer Aridis files for $34.5M IPO
